EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Complement C5a Fosters Tumor-promoting Immunity by Recruiting regulatory T cells in hepatocellular carcinoma

Run Huang, Tianhao Chu, Guiqi Zhu, Chenyang Tao, Weifeng Qu, Yuan Fang, Jun Gao, Xiutao Fu, Zhenbin Ding, Weiren Liu, Jian Zhou, Yinghong Shi und 2 weitere

Cancer Letters · 2026

DOI: 10.1016/j.canlet.2026.218818 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von Run Huang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Breast Surgery, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Liver Surgery, Liver Cancer Institute,…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Carcinoma, Hepatocellular, Liver Neoplasms, Complement C5a. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anaphylatoxins are active complement components that regulate immune cells. However, their role in shaping the tumor immune microenvironment (TIME) in hepatocellular carcinoma (HCC) remains poorly understood. This study utilized CRISPR/Cas9 technology to knock out complements proteins C3 or C5 in mouse liver cancer cells. Both in vivo and in vitro experiments revealed that C5 knockout significantly inhibited tumor growth in mouse models. Moreover, C5ar1-knockout mice were generated using C57BL/6 J mice, and immune cell profiles within subcutaneous tumors were analyzed using mass spectrometry and flow cytometry. The results demonstrated that C5ar1 knockout significantly reduced the infiltration of regulatory T cells (Tregs) and M2-like tumor-associated macrophages (TAMs) into the TIME. Conversely, the infiltration of effector CD8+ T cells, known for their tumor-killing activity, was markedly enhanced. Mechanistically, C5a was shown to promote the M2-like polarization of macrophages and the C-C-motif chemokine ligand 5 (CCL5) expression by activating the AKT signaling pathway. Further studies identified TAM-derived CCL5 as a key driver of the chemotactic activity of Tregs. Finally, blocking the C5a/C5ar1 axis synergistically enhanced the anti-tumor effects of PD-1 monoclonal antibody in both transplanted and spontaneous liver cancer mouse models. Overall, these findings reveal that cancer cell-derived anaphylatoxin C5a plays a pivotal role in promoting an inhibitory TIME in liver tumor tissues. Blocking the C5a/C5ar1 axis in combination with immune checkpoint inhibitors could represent a promising strategy for treating HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryCarcinoma, HepatocellularLiver NeoplasmsComplement C5aAnimalsMiceReceptor, Anaphylatoxin C5aTumor MicroenvironmentMice, KnockoutTumor-Associated MacrophagesMice, Inbred C57BLChemokine CCL5HumansCell Line, TumorSignal TransductionComplement C3

Stichwörter der Autor:innen

Complement systemHepatocellular carcinomaImmunotherapyTumor immune microenvironment (TIME)Tumor-associated macrophages (TAMs)

Substanzen

Receptor, Anaphylatoxin C5aComplement C5aC5ar1 protein, mouseChemokine CCL5Ccl5 protein, mouseComplement C3C3 protein, mouse

Autor:innen und Institutionen

  • Department of Thyroid and Breast Surgery, Zhongshan Hospital, Fudan University, Shanghai, China; Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: shi.yinghong@zs-hospital.sh.cn.
  • Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: fan.jia@zs-hospital.sh.cn.
  • Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: tang.zheng@zs-hospital.sh.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Huang, R., Chu, T., Zhu, G., Tao, C., Qu, W., Fang, Y., Gao, J., Fu, X., Ding, Z., Liu, W., Zhou, J., Shi, Y., Fan, J., & Tang, Z. (2026). Complement C5a Fosters Tumor-promoting Immunity by Recruiting regulatory T cells in hepatocellular carcinoma. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218818

Vancouver

Huang R, Chu T, Zhu G, Tao C, Qu W, Fang Y, et al. Complement C5a Fosters Tumor-promoting Immunity by Recruiting regulatory T cells in hepatocellular carcinoma. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218818

BibTeX
@article{Huang2026,
  author = {Huang, Run and Chu, Tianhao and Zhu, Guiqi and Tao, Chenyang and Qu, Weifeng and Fang, Yuan and Gao, Jun and Fu, Xiutao and Ding, Zhenbin and Liu, Weiren and Zhou, Jian and Shi, Yinghong and Fan, Jia and Tang, Zheng},
  title = {Complement C5a Fosters Tumor-promoting Immunity by Recruiting regulatory T cells in hepatocellular carcinoma},
  journal = {Cancer Letters},
  year = {2026},
  doi = {10.1016/j.canlet.2026.218818}
}
Kostenlos starten →